Tags: Menopause | Osteoporosis | duavee | menopause | drug | hot | flash

FDA OKs Drug That Reduces Hot Flashes With Fewer Side Effects

U.S. health regulators approved Pfizer Inc's menopause drug Duavee, which the company hopes will reduce hot flashes with fewer side effects than older hormone-replacement therapies.

The Food and Drug Administration said on Thursday it approved the drug to treat women with moderate to severe menopause symptoms and to prevent post-menopausal osteoporosis, a bone disease which can increase the risk of fractures.

The drug, which Pfizer is developing with Ligand Pharmaceuticals Inc, combines bazedoxifene - which belongs to a class of drugs known as selective estrogen receptor modulators, or SERMS - and conjugated estrogens, which are derived from the urine of pregnant horses and contained in Pfizer's menopause drug Premarin.

© 2015 Thomson/Reuters. All rights reserved.

1Like our page
2Share
Health-News
U.S. health regulators approved Pfizer Inc's menopause drug Duavee,which the company hopes will reduce hot flashes with fewer side effects than older hormone-replacement therapies. The Food and Drug Administration said on Thursday it approved the drug to treat women...
duavee,menopause,drug,hot,flash,pfizer
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved